Literature DB >> 20133024

In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives.

Kavitha C S Achar1, Kallappa M Hosamani, Harisha R Seetharamareddy.   

Abstract

A series of 2-methylaminobenzimidazole derivatives (1-11) were synthesized by the reaction of 2-(chloromethyl)-1H-benzimidazole derivatives with primary aromatic amines. All these compounds were characterized by IR, 1H NMR, 13C NMR, GC-MS and elemental analysis. The newly synthesized compounds were screened for analgesic and anti-inflammatory activities on acetic acid induced writhing in mice and carrageenan induced paw oedema in rats. Compounds (7) and (2) showed a potent analgesic (89% at 100 mg/kg b.w) and anti-inflammatory (100% at 100 mg/kg b.w) activities compared with standard drug Nimesulide (100% at 50 mg/kg b.w) respectively. The other compounds showed good analgesic and anti-inflammatory activities. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133024     DOI: 10.1016/j.ejmech.2010.01.029

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  25 in total

1.  Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner.

Authors:  Karthik Sambanthamoorthy; Ankush A Gokhale; Weiwei Lao; Vijay Parashar; Matthew B Neiditch; Martin F Semmelhack; Ilsoon Lee; Christopher M Waters
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

2.  Synthesis, characterisation and evaluation of N-mannich bases of 2-substituted Benzimidazole derivatives.

Authors:  Sekar Vinoth Kumar; Mohan Raj Subramanian; Santhosh Kumar Chinnaiyan
Journal:  J Young Pharm       Date:  2013-12-11

3.  Synthesis, anti-inflammatory, and antiproliferative activity evaluation of isoindole, pyrrolopyrazine, benzimidazoisoindole, and benzimidazopyrrolopyrazine derivatives.

Authors:  Sandeep Kumar; Nikhil Kumar; Partha Roy; Sham M Sondhi
Journal:  Mol Divers       Date:  2013-08-27       Impact factor: 2.943

4.  Pyrimido[1,2-a]benzimidazoles: synthesis and perspective of their pharmacological use.

Authors:  Victor V Fedotov; Vladimir L Rusinov; Evgeny N Ulomsky; Evgeny M Mukhin; Evgeny B Gorbunov; Oleg N Chupakhin
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-15       Impact factor: 1.490

5.  Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein.

Authors:  Manar I Nagy; Khaled M Darwish; Safaa M Kishk; Mohamed A Tantawy; Ali M Nasr; Mona Qushawy; Shady A Swidan; Samia M Mostafa; Ismail Salama
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-01

6.  Ethyl 1-(2-hy-droxy-eth-yl)-2-phenyl-1H-benzimidazole-5-carboxyl-ate.

Authors:  Nurasyikin Hamzah; Shafida Abd Hamid; Aisyah Saad Abdul Rahim; Mohd Mustaqim Rosli; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-26

7.  Synthesis and insight into the structure-activity relationships of 2-phenylbenzimidazoles as prospective anticancer agents.

Authors:  Thi-Kim-Chi Huynh; Thi-Hong-An Nguyen; Thi-Cam-Thu Nguyen; Thi-Kim-Dung Hoang
Journal:  RSC Adv       Date:  2020-06-01       Impact factor: 4.036

8.  2-Thio-ureido-1H-benzimidazol-3-ium chloride monohydrate.

Authors:  C N Sundaresan; Dheeraj Kumar Singh; Jagadeesh Babu Nanubolu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-04-16

9.  1-Methyl-2-methyl-sulfanyl-6-nitro-1H-benzimidazole.

Authors:  Mohamed El Ghozlani; El Mostapha Rakib; Abdelouahid Medaghri-Alaoui; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-03-08

10.  Crystal structure of 1-methyl-2-[(E)-2-(4-methyl-phen-yl)ethen-yl]-4-nitro-1H-imidazole.

Authors:  Hayette Alliouche; Abdelmalek Bouraiou; Sofiane Bouacida; Hocine Merazig; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.